Literature DB >> 8807075

Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2).

M Gazouli1, L S Tzouvelekis, E Prinarakis, V Miriagou, E Tzelepi.   

Abstract

Cefoxitin resistance in Klebsiella pneumoniae from Escherichia coli strains isolated in Greek hospitals was found to be due to the acquisition of similar plasmids coding for group 1 beta-lactamases. The plasmids were not self-transferable but were mobilized by conjugative plasmids. These elements have also been spread to Enterobacter aerogenes. The most common enzyme was a Citrobacter freundii-derived cephalosporinase (LAT-2) which differed from LAT-1 by three amino acids.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8807075      PMCID： PMC163408     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

Review 1.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

2.  Plasmid-mediated production of class I (AmpC) beta-lactamase by two Klebsiella pneumoniae isolates from the UK.

Authors:  P J Jenks; Y M Hu; F Danel; S Mehtar; D M Livermore
Journal:  J Antimicrob Chemother       Date:  1995-01       Impact factor: 5.790

3.  Nucleotide sequence of a plasmid-mediated cephalosporinase gene (blaLAT-1) found in Klebsiella pneumoniae.

Authors:  L S Tzouvelekis; E Tzelepi; A F Mentis
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

4.  Characterization of a plasmid-borne and constitutively expressed blaMOX-1 gene encoding AmpC-type beta-lactamase.

Authors:  T Horii; Y Arakawa; M Ohta; T Sugiyama; R Wacharotayankun; H Ito; N Kato
Journal:  Gene       Date:  1994-02-11       Impact factor: 3.688

5.  Cloning and sequence analysis of blaBIL-1, a plasmid-mediated class C beta-lactamase gene in Escherichia coli BS.

Authors:  A P Fosberry; D J Payne; E J Lawlor; J E Hodgson
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

6.  Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance.

Authors:  A Bauernfeind; I Stemplinger; R Jungwirth; H Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Sequence of the Citrobacter freundii OS60 chromosomal ampC beta-lactamase gene.

Authors:  F Lindberg; S Normark
Journal:  Eur J Biochem       Date:  1986-05-02

9.  Production of a plasmid mediated AmpC-like beta-lactamase by a Klebsiella pneumoniae septicaemia isolate.

Authors:  K J Pörnull; G Rodrigo; K Dornbusch
Journal:  J Antimicrob Chemother       Date:  1994-12       Impact factor: 5.790

10.  beta-Lactamases and beta-lactam resistance in Escherichia coli.

Authors:  G A Jacoby; L Sutton
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191
View more
  27 in total

1.  Rare case of failure by an automated system to detect extended-spectrum beta-lactamase in a cephalosporin-resistant Klebsiella pneumoniae isolate.

Authors:  L S Tzouvelekis; A C Vatopoulos; G Katsanis; E Tzelepi
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia.

Authors:  A Bauernfeind; I Schneider; R Jungwirth; H Sahly; U Ullmann
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

3.  BetalasEN: microdilution panel for identifying beta-lactamases present in isolates of Enterobacteriaceae.

Authors:  Christine C Sanders; Anton F Ehrhardt; Ellen Smith Moland; Kenneth S Thomson; Barbara Zimmer; Darcie E Roe
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

Review 4.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

5.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

6.  Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein.

Authors:  P D Stapleton; K P Shannon; G L French
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

7.  CMY-13, a novel inducible cephalosporinase encoded by an Escherichia coli plasmid.

Authors:  V Miriagou; L S Tzouvelekis; L Villa; E Lebessi; A C Vatopoulos; A Carattoli; E Tzelepi
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

8.  Emergence of DHA-1-producing Klebsiella spp. in the Parisian region: genetic organization of the ampC and ampR genes originating from Morganella morganii.

Authors:  Charlotte Verdet; Yahia Benzerara; Valérie Gautier; Olivier Adam; Zahia Ould-Hocine; Guillaume Arlet
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

9.  Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of bla(TEM) genes.

Authors:  V Leflon-Guibout; V Speldooren; B Heym; M Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

10.  Sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome in Greek hospitals.

Authors:  L S Tzouvelekis; E Tzelepi; E Prinarakis; M Gazouli; A Katrahoura; P Giakkoupi; O Paniara; N J Legakis
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.